|Assessment Status||Rapid Review Complete|
|Indication||For the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.|
|Rapid review commissioned||28/06/2016|
|Rapid review completed||26/07/2016|
|Rapid review outcome||Full Pharmacoeconomic Assessment Recommended at the submitted price|
The HSE has approved reimbursement following confidential price negotiations.